In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in ...

ZoaDx, a newly launched clinical research organization, is dedicated to advancing animal health and agricultural sustainability through expert clinical research, tailored regulatory solutions, and ...

The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the ...

Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a leading healthcare company in Korea, announced the official launch of its high-purity, high-quality botulinum toxin product, NABOTA ...

GCCL enhances quality assurance through advanced technology integration, effectively minimizing errors, improving precision, and ensuring data reliability. By implementing the BIO-RAD Evolis system ...

Surplus Solutions, a global leader in Equipment Lifecycle Management (ELM) services, specializing in procuring and reselling laboratory, processing, and packaging equipment is ...

Stability Testing Course for Pharmaceuticals and BiopharmaceuticalsDublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Stability Testing of Pharmaceuticals and Biopharmaceuticals Training Course (ONLINE ...

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...